Al-Momani Hafez, Aolymat Iman, Almasri Muna, Mahmoud Sameer Alhaj, Mashal Safaa
Department of Microbiology, Pathology & Forensic medicine, Faculty of Medicine, The Hashemite University, PO box 330127, Zarqa 13133, Jordan.
Department of Anatomy, Physiology & Biochemistry, Faculty of Medicine, The Hashemite University, PO box 330127, Zarqa 13133, Jordan.
Future Sci OA. 2023 Apr 21;9(5):FSO858. doi: 10.2144/fsoa-2023-0040. eCollection 2023 Jun.
This study examined the various manifestations of COVID-19 in people's gastro-intestinal system and how gastro-intestinal involvement relates to the progression and outcome of the disease.
A questionnaire survey was used to collect data from 561 COVID-19 patients between February 6 and 6 April 2022. Laboratory data and clinical outcomes were obtained from the patients' medical records.
39.9% of patients presented gastro-intestinal symptoms, mainly loss of appetite, nausea, vomiting and diarrhea. Gastro-intestinal symptoms were not linked to poorer outcomes such as mortality, ICU admission or length of hospital stays.
gastro-intestinal symptoms were common among patients and may manifest with respiratory symptoms. We recommended clinicians to watch out for gastro-intestinal symptoms as related to COVID-19 infection.
本研究调查了新冠病毒病（COVID-19）在人体胃肠道系统的各种表现，以及胃肠道受累与疾病进展和结局的关系。
采用问卷调查法收集了2022年2月6日至4月6日期间561例COVID-19患者的数据。实验室数据和临床结局从患者的病历中获取。
39.9%的患者出现胃肠道症状，主要为食欲不振、恶心、呕吐和腹泻。胃肠道症状与死亡率、入住重症监护病房或住院时间等较差结局无关。
胃肠道症状在患者中很常见，可能与呼吸道症状同时出现。我们建议临床医生留意与COVID-19感染相关的胃肠道症状。
